Acquisition of c-LEcta
15 February 2022
Kerry Group plc (“Kerry”), the global taste and nutrition company, today announces it has reached agreement to acquire c. 92% of the issued share capital of c-LEcta GmbH (“c-LEcta”) for a consideration of € 137 million, with management to retain the balance.
c-LEcta is a leading biotechnology company located in Leipzig, Germany. The company has established itself as a leading player in the realisation of high-value biotechnology products for regulated markets, either as in-house development or in close cooperation with the industry. c-LEcta innovation capability delivers cost-efficient and sustainable production processes, creating growth opportunities across existing and new markets.
Capricorn Sustainable Chemistry Fund and Quest for Growth, both managed by Capricorn Partners, invested in the company in 2018. Ludwig Goris, Investment Director at Capricorn Partners and representing both funds in the board of directors of c-LEcta comments: “This successful exit confirms and supports our ambitious investment strategy to focus on unique companies with a technology platforms that are unparalleled in its sort. We are extremely pleased to have worked with dr. Marc Struhalla and his excellent management team. They accomplished a stellar growth trajectory in all aspects in just four years’ time.”